These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3528860)

  • 21. Interferon and natural killer cells in murine Chagas' disease.
    Quan PC; Rager-Zisman B; Wittner M; Tanowitz HB
    J Parasitol; 1983 Dec; 69(6):1164-6. PubMed ID: 6201603
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
    Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NKG2D ligands: key targets of the immune response.
    González S; López-Soto A; Suarez-Alvarez B; López-Vázquez A; López-Larrea C
    Trends Immunol; 2008 Aug; 29(8):397-403. PubMed ID: 18602338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerant T cells inhibit natural killer cells function in antigen-presenting cells in an independent fashion.
    Wang X; Yuan J; Hu J; Wu J; Gan C; He W; Luo G
    Transplant Proc; 2009 Jun; 41(5):1844-7. PubMed ID: 19545741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunological status in clinical medicine].
    Zimin IuI; Vasil'eva EV; Sura VV
    Ter Arkh; 1982; 54(12):98-108. PubMed ID: 6760442
    [No Abstract]   [Full Text] [Related]  

  • 26. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing.
    Salata RA; Kleinhenz ME; Schacter BZ; Ellner JJ
    Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological aspects of lymphocyte mediated cytotoxicity.
    Sanderson CJ
    Adv Exp Med Biol; 1982; 146():3-21. PubMed ID: 6980565
    [No Abstract]   [Full Text] [Related]  

  • 28. [Endogenous opiate neuropeptides and the immune system].
    Vasil'eva EV; Sukhikh GT; Vinogradov VA; Sura VV
    Ter Arkh; 1984; 56(10):120-5. PubMed ID: 6098041
    [No Abstract]   [Full Text] [Related]  

  • 29. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition/adhesion step.
    Tsoukas CD; Carson DA; Fong S; Vaughan JH
    J Immunol; 1982 Oct; 129(4):1421-5. PubMed ID: 6286765
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytotoxic activity of normal killer cells in partially hepatectomized mice].
    Avtsyn AP; Babaeva AG; Van'ko LV; Sukhikh GT; Iudina NV
    Dokl Akad Nauk SSSR; 1983; 271(6):1514-6. PubMed ID: 6605240
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DNA damage response arouses the immune system.
    Gasser S; Raulet DH
    Cancer Res; 2006 Apr; 66(8):3959-62. PubMed ID: 16618710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptors for immunoglobulins and activation markers on human T lymphocytes.
    Moretta A; Mingari MC; Corte G; Moretta L
    Clin Haematol; 1982 Oct; 11(3):697-709. PubMed ID: 6217008
    [No Abstract]   [Full Text] [Related]  

  • 35. Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine.
    Warren HS
    J Immunol; 1984 Jun; 132(6):2888-94. PubMed ID: 6233364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies.
    Woda BA; McFadden ML; Welsh RM; Bain KM
    J Immunol; 1984 May; 132(5):2183-4. PubMed ID: 6609190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
    Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
    Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Natural cytotoxicity in systemic lupus erythematosus patients].
    Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
    Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
    [No Abstract]   [Full Text] [Related]  

  • 39. A serine proteinase as a "trigger" for human natural killer lymphocyte-mediated cytolysis.
    Hudig D; Minning L; Redelman D
    Adv Exp Med Biol; 1985; 184():271-80. PubMed ID: 3898751
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism of tumor cell lysis by natural killer cells.
    Goldfarb RH; Timonen T; Herberman RB
    Adv Exp Med Biol; 1982; 146():403-21. PubMed ID: 6285682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.